📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
TATVA CHINTAN PHARMA CHEM LIMITEDTATVASpecialty Chemicals
Open
1249.9
High
1263.4
Low
1179.1
Close
1187.7
Volume
92168
Exchange
nse
Time
21-May-2026

Outlook

Score:

0.5

Rating:

RISKY

Candlestick Pattern

CandlepatternofTatvaChintanPharmaChemis
Long Body
EstimatedStoplossofTatvaChintanPharmaChemis
1263.4
TatvaChintanPharmaChemhasa
Bearishℹ
pattern.
Formationof
Long Body
candlepatternindicatesthetrenddirectionofTatvaChintanPharmaChemmaybe
Unpredictableℹ
,butkeepalookoutforfallinprice.

Trend

TatvaChintanPharmaChemisin
Sideways trendℹ
.
PriceofTatvaChintanPharmaChemis
Downℹ
by

4.43

%.
Target
Buy@

1063.17

Sell@

1369.43

Current@

1187.7

Volume

ThetradesofTatvaChintanPharmaChemhavebeenin
Immenseℹ
volume.
ThevolumetradesforTatvaChintanPharmaChemare
Bearishℹ
with
Strong Sellersℹ
ThetradevolumeofTatvaChintanPharmaChemis

Up

by

70.54

%

Valuation

ThecurrentmarketpriceofTatvaChintanPharmaChemis
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth836crandtotalassetsworth836cr,thebalancesheetofTatvaChintanPharmaChemis:
Balancedℹ
.
Cashflow
TatvaChintanPharmaChemhas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 23cr

.Itis
Downℹ
by

428.57

%.
22.86% i.e. ₹ 24cr earned in operatingℹ
61.9% i.e. ₹ 65cr spent in investingℹ
15.24% i.e. ₹ 16cr earned in financingℹ
0% in otherℹ
TatvaChintanPharmaChemhas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 7cr

.Itis
Upℹ
by

120

%.
39.52% i.e. ₹ 98cr earned in operatingℹ
48.39% i.e. ₹ 120cr spent in investingℹ
12.1% i.e. ₹ 30cr earned in financingℹ
0% in otherℹ
Income
TheincomeofTatvaChintanPharmaChemis

₹ 124cr

and

Profit

is:

₹ 9cr

TatvaChintanPharmaChemProfitisupby:

500

%andIncomeisUpby:

9.26

%
TheincomeofTatvaChintanPharmaChemis

₹ 118cr

and

Profit

is:

₹ 6cr

TatvaChintanPharmaChemProfitisupby:

100

%andIncomeisUpby:

27.06

%
TheincomeofTatvaChintanPharmaChemis

₹ 108cr

and

Loss

is:

₹ 1cr

TatvaChintanPharmaChemLossesincreasedby:

0

%andIncomeisUpby:

2.41

%
By using this site you agree to the use of cookies to deliver a better site experience.